About Nam Pham — Pharmaceutical Automation Specialist

## Nam Pham — Pharmaceutical Automation Specialist Nam Pham is a pharmaceutical automation and smart factory specialist based in Vietnam, with over a decade of hands-on experience delivering ISA-95 architectures, MES/EBR implementations, GxP validation programs, and ALCOA+ data integrity remediation for pharmaceutical manufacturers across Vietnam and Southeast Asia. ### Professional Background Nam Pham's career spans the full lifecycle of pharmaceutical manufacturing digitalization — from brownfield OT/IT gap assessment through to validated system deployment and regulatory inspection readiness. The practice covers sterile injectables, oral solid dosage (OSD), biologics and biosimilars, active pharmaceutical ingredients (APIs), traditional medicines, and medical devices. Core technical areas include: - **ISA-95 architecture** — production planning layers (L1–L4), MES/EBR integration, data flow design between plant floor systems and enterprise ERP - **GxP validation** — Computer System Validation (CSV), Computer Software Assurance (CSA), GAMP 5 risk-based approaches, IQ/OQ/PQ protocol authoring and execution, Validation Master Plan (VMP) governance - **Data integrity (ALCOA+)** — audit trail review, electronic records and signatures (21 CFR Part 11, EU GMP Annex 11), data integrity gap assessment and remediation roadmaps - **QMS/LIMS integration** — quality management workflow, laboratory information management, deviation and CAPA tracking, change control frameworks - **OT cybersecurity** — IEC 62443 zone-and-conduit models, OT network segmentation, vendor assessment for GMP environments - **MES and EBR selection** — vendor evaluation frameworks, S88 batch recipe management, paperless batch record deployment, weigh-and-dispense verification ### Industry Focus The geographic focus is Vietnam (primary market) and Southeast Asia — Singapore, Thailand, Malaysia, Indonesia, Philippines — with cross-border programs in India, China, and global pharmaceutical teams operating in the Asia region. Industries served: sterile manufacturing, oral solid dosage, biologics, API synthesis, traditional medicine (TCM), veterinary pharmaceuticals, and regulated medical devices. Working languages: Vietnamese (native), English (professional working proficiency for regulatory documentation, vendor negotiations, and international project teams). ### Approach to Pharmaceutical Digitalization The philosophy behind the practice is grounded in a single observation: most Vietnamese pharmaceutical manufacturers are running brownfield facilities built before digital systems were a regulatory expectation. The challenge is not implementing the newest technology — it is validating the existing technology, closing the data integrity gaps already present, and building a sustainable operating model that will hold up under PICS, FDA, and EU GMP inspection. This means prioritizing validation evidence over vendor promises, documented operating procedures over software features, and phased implementation plans over big-bang deployments. Every engagement starts with a current-state assessment, a gap map against the applicable regulatory standard, and a sequenced roadmap that accounts for production constraints. ### Professional Memberships and Development - Member, International Society for Pharmaceutical Engineering (ISPE) - Active participant in ISPE Asia-Pacific regional programs - Ongoing engagement with PDA (Parenteral Drug Association) technical resources - Regular review of FDA guidance documents, EMA reflection papers, and ICH Q10/Q12 lifecycle management standards ### Publications and Reference Work Technical articles, implementation guides, and analysis published at [nampham.net/blog](/blog) cover ISA-95, MES/EBR, GxP validation, ALCOA+ data integrity, OT cybersecurity, and AI readiness for pharmaceutical manufacturing. A consolidated list is available at [/about/publications](/about/publications). ### Contact For project inquiries, validation consulting, or technical discussions: [Contact Nam Pham](/contact).